跳至主要内容
临床试验/CTRI/2024/06/068903
CTRI/2024/06/068903尚未招募Phase 3 4

A Randomized Comparative Clinical Study to Evaluate the Efficacy of Trikantaka Beeja Churna Over Tilanala Kshara in the Management of Mutrashmari with Special Reference to Urolithiasis

未提供1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2024年7月1日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
入组人数
56
试验地点
1
主要终点
Reduction in the size of calculi

研究概览

简要总结

This study is comparative clinical study to evaluate the efficacy of tilanala kshara kshaara over trikantaka beeja churna in the management of mutrashmari, as kidney stones are very common in the present generation and produces more pain which is untolerable. Modern medicines are very costly to purchase for poor persons so the present study drug will be of low cost so everyone can afford and the drug is having ksharana and  lekhana property it helps to prevent the renal calculi so, this study will be conducted in BLDEAs AVS Ayurveda Mahavidyalaya, Hospital and Research Centre, Vijayapura 586109 Karnataka , India

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
16.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients fufiling diagnostic criteria Presence of calculi from 4mm to 8mm size, confirmed by USG either unilaterally or bilaterally Patients with solitary or multiple calculi Pain with or without haematuria Pain with or without dysuria.

排除标准

  • Patients with renal calculi and complications like severe hydronephrosis, glomerular nephritis and chronic renal failure Patients with other systemic disorders like Diabetes, HTN, TB, HIV, hepatitis B, Veneral diseases and renal carcinoma Pregnant women and lactating mother Paneeya kshara anarha patients Staghorn calculi.

结局指标

主要结局

Reduction in the size of calculi

时间窗: 4 weeks

Expulsion of the calculi

时间窗: 4 weeks

次要结局

  • Subsiding of other symptoms(4 weeks)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

DR KORE AMASIDHA LAXMAN

BLDE ASSOCIATIONS AVS AYURVEDA MAHAVIDYALAYA HOSPITAL AND RESEARCH CENTRE

研究点 (1)

Loading locations...

相似试验